EleFirst Science & Technology Co Ltd
SZSE:300356
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (49.8), the stock would be worth ¥-25.78 (1 625% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.3 | ¥1.69 |
0%
|
| Industry Average | 49.8 | ¥-25.78 |
-1 625%
|
| Country Average | 28.8 | ¥-14.92 |
-983%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
EleFirst Science & Technology Co Ltd
SZSE:300356
|
689.4m CNY | -3.3 | -2.5 | |
| JP |
|
Keyence Corp
TSE:6861
|
15.3T JPY | 22.6 | 34.4 | |
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
59.6B USD | 49.1 | 62 | |
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
306.9B CNY | 15 | 20.5 | |
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
30B USD | 20.5 | 32.2 | |
| SE |
|
Hexagon AB
STO:HEXA B
|
274.2B SEK | 15.5 | 12.5 | |
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
192.9B CNY | 2 350.2 | 1 890.2 | |
| TW |
|
Chroma ATE Inc
TWSE:2360
|
821.8B TWD | 81.4 | 70.3 | |
| UK |
|
Halma PLC
LSE:HLMA
|
16.8B GBP | 28.5 | 48.2 | |
| CN |
|
Huagong Tech Co Ltd
SZSE:000988
|
118.3B CNY | 76.3 | 80.4 | |
| US |
|
Trimble Inc
NASDAQ:TRMB
|
15.9B USD | 20.6 | 37.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.3 |
| Median | 28.8 |
| 70th Percentile | 53.1 |
| Max | 49 021 |
Other Multiples
EleFirst Science & Technology Co Ltd
Glance View
EleFirst Science & Tech Co., Ltd. engages in the development, manufacture, and sale of intelligent information collection systems. The company is headquartered in Nanjing, Jiangsu and currently employs 478 full-time employees. The company went IPO on 2012-09-24. The firm is principally involved in the research, development, manufacture and sale of pharmaceutical products. The firm's main products include compound dichloroacetic acid diisopropylamine for injection, amifostine for injection, clindamycin phosphate for injection and urokinase for injection. The firm distributes its products in domestic market.
